pd 145065 has been researched along with bay-k-8644 in 1 studies
| Studies (pd 145065) | Trials (pd 145065) | Recent Studies (post-2010) (pd 145065) | Studies (bay-k-8644) | Trials (bay-k-8644) | Recent Studies (post-2010) (bay-k-8644) |
|---|---|---|---|---|---|
| 76 | 1 | 5 | 2,555 | 0 | 144 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Held, B; Pearson, HA; Pocock, JM | 1 |
1 other study(ies) available for pd 145065 and bay-k-8644
| Article | Year |
|---|---|
Endothelin-1 inhibits voltage-sensitive Ca2+ channels in cultured rat cerebellar granule neurones via the ET-A receptor.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; Animals; Calcium Channel Blockers; Calcium Channels; Calcium Channels, L-Type; Calcium Signaling; Cerebellum; Dose-Response Relationship, Drug; Endothelin-1; Male; Nerve Tissue Proteins; Neurons; Oligopeptides; Patch-Clamp Techniques; Peptides, Cyclic; Potassium; Potassium Chloride; Rats; Rats, Wistar; Receptor, Endothelin A; Receptors, Cholinergic; Receptors, Endothelin; Second Messenger Systems; Viper Venoms | 1998 |